Remission From Behavioral Dysregulation in a Child With PTSD After Receiving Procedural Ketamine - Wikidata - wikimedia - TriplyDB

Remission From Behavioral Dysregulation in a Child With PTSD After Receiving Procedural Ketamine

Remission From Behavioral Dysregulation in a Child With PTSD After Receiving Procedural Ketamine

http://www.wikidata.org/entity/Q26799619

about

Ketamine: 50 Years of Modulating the Mind Ketamine for Treatment of Suicidal Ideation and Reduction of Risk for Suicidal Behavior.A retrospective study of ketamine administration and the development of acute or post-traumatic stress disorder in 274 war-wounded soldiers.

P2860

Q28077524-5D4CD5FB-34F0-477E-B657-08D2F76BB105 Q38837851-305BDCB8-BA82-4533-9DF5-D3CCCE878802 Q47246046-99EA3670-4021-4110-B4CC-A3A701934E96

P2860

Remission From Behavioral Dysregulation in a Child With PTSD After Receiving Procedural Ketamine

http://www.wikidata.org/entity/Q26799619

description

2015 nî lūn-bûn

@nan

2015 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Remission From Behavioral Dysr ...... Receiving Procedural Ketamine

@ast

Remission From Behavioral Dysr ...... Receiving Procedural Ketamine

@en

Remission From Behavioral Dysr ...... Receiving Procedural Ketamine

@nl

type

label

Remission From Behavioral Dysr ...... Receiving Procedural Ketamine

@ast

Remission From Behavioral Dysr ...... Receiving Procedural Ketamine

@en

Remission From Behavioral Dysr ...... Receiving Procedural Ketamine

@nl

prefLabel

Remission From Behavioral Dysr ...... Receiving Procedural Ketamine

@ast

Remission From Behavioral Dysr ...... Receiving Procedural Ketamine

@en

Remission From Behavioral Dysr ...... Receiving Procedural Ketamine

@nl

P1433

Q26799619-EECD84E1-867B-4BC5-91D7-AC8E2E0A45AD

P1476

Q26799619-69922AF0-1CAA-4525-AC1B-684DB0A9CC89

P2093

Q26799619-4D123E76-65BF-41A7-A89F-48B136D301BA

Q26799619-8175D745-0036-4679-B436-1749ED582C0A

Q26799619-FF199D37-77DA-4501-BED0-2A1C54BFA3AF

P2860

Q26799619-1047B1DC-471E-4BE6-A7F8-F846408F6304

Q26799619-1786EB6D-D90D-4102-9FF4-8C2C6DA68D9B

Q26799619-1E452C6B-755B-4783-B5D6-D47DE3B9525F

Q26799619-3A90C585-0FE0-472E-9E57-EE4602C94E46

Q26799619-40D17771-06FE-45DE-8AD5-80C2E15D8B89

Q26799619-4B0006A0-3177-4B8C-A136-DA78D3BCAFA7

Q26799619-515DB7B3-3D82-4819-B798-F73A65FE36B5

Q26799619-BCD372D9-9D09-4A3D-AAFE-A63FDD4647DB

Q26799619-BE228FD0-7340-461D-8F7F-9E260EC688D5

Q26799619-BF31DA9E-2704-41F8-97F2-3766D6651665

P304

Q26799619-8773D609-D671-4F35-85F9-F1B327B6817A

P31

Q26799619-F7B3288D-9BA6-4512-824D-591E36ADE5DC

P356

Q26799619-5F77A20F-4229-4FD7-8164-D27DB9D3AA87

P407

Q26799619-2EF144BB-1C8A-491F-A0E1-1DD15EAF2B9A

P433

Q26799619-E3E2E2ED-7199-4008-9262-9CB6158B7B56

P478

Q26799619-CDCA0EC7-1787-45E8-8CEC-FB2659EF49B4

P577

Q26799619-93853348-BB7C-4864-B5E5-EBD5B34589F8

P698

Q26799619-1C477D61-B3D2-460C-A231-46A3803BF5E6

P921

Q26799619-4522E3C8-02D8-4343-8FFC-95135287BB89

P932

Q26799619-C1B3F3F4-0C15-49D4-8B58-A2277A6A2E15

P356

P1433

P1476

Remission From Behavioral Dysr ...... Receiving Procedural Ketamine

@en

P2093

Anna C Donoghue

http://www.w3.org/2001/XMLSchema#string

Kathryn R Cullen

http://www.w3.org/2001/XMLSchema#string

Mark G Roback

http://www.w3.org/2001/XMLSchema#string

P2860

Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants

Neurotrophins: roles in neuronal development and function

Practice parameter for the assessment and treatment of children and adolescents with reactive attachment disorder of infancy and early childhood

mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists

Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial.

Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: a randomized clinical trial.

Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure.

Prior exposure to interpersonal violence and long-term treatment response for boys with a disruptive behavior disorder

Clinical experience using intranasal ketamine in the treatment of pediatric bipolar disorder/fear of harm phenotype.

Ketamine administration in depressive disorders: a systematic review and meta-analysis.

P304

e694-6

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1542/PEDS.2014-4152

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

136

http://www.w3.org/2001/XMLSchema#string

P577

2015-08-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26260717

http://www.w3.org/2001/XMLSchema#string

P921

post-traumatic stress disorder

P932

5534263

http://www.w3.org/2001/XMLSchema#string